Easywell Biomedicals, Inc. (TPEX:1799)

Taiwan · Delayed Price · Currency is TWD

32.45

-2.95 (-8.33%)

Jul 29, 2026, 1:30 PM CST

Easywell Biomedicals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	682.56	597.41	540.44	271.63	178.9	197.28
Revenue Growth	10.35%	10.54%	98.96%	51.84%	-9.32%	-26.29%
Gross Profit	320.18	280.31	299.4	170.72	76.31	50.43
Operating Income	-43.65	-67.2	-74.79	-162.74	-161.26	-211.86
Net Income	-52.13	-73.14	-97.47	-144.82	-161	-150.39
Earnings Per Share	-0.42	-0.59	-0.81	-1.27	-1.41	-1.41
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
America	235.15	326.15	271.63	178.82	191.97
China	361.82	214.17	-	-	-
Taiwan	0.44	0.12	-	-	-
Total	597.41	540.44	271.63	178.9	197.28

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	453.57	451.69	466.1	348.03	339.54	439.28
Total Debt	430.24	425.91	564.28	386.34	349.96	325.5
Net Cash (Debt)	23.33	25.78	-98.19	-38.31	-10.42	113.78
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.19	0.21	-0.82	-0.33	-0.09	1.07

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	160.52	124.78	-159.04	-151.45	-53.5	-128.31
Capital Expenditures	-12.31	-15.41	-12.49	-17.73	-7.49	-7.71
Free Cash Flow	148.21	109.37	-171.53	-169.17	-60.99	-136.02
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	46.91%	46.92%	55.40%	62.85%	42.66%	25.56%
Operating Margin	-6.40%	-11.25%	-13.84%	-59.91%	-90.14%	-107.39%
Pretax Margin	-7.65%	-12.58%	-16.34%	-62.55%	-94.06%	-86.00%
Profit Margin	-7.64%	-12.24%	-18.04%	-53.31%	-90.00%	-76.23%
FCF Margin	21.71%	18.31%	-31.74%	-62.28%	-34.09%	-68.95%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	27.30	40.82	-	-	-	-
PS Ratio	5.93	7.47	14.50	17.62	10.26	13.17